NT vs Observe.

NT-proBNP algorithms for the diagnosis of Heart Failure in three settings: - Acute Heart Failure - Chronic Heart Failure - Primary Prevention of Heart failure in Diabetic patients Important Notice: This algorithm, by measuring the cardiac biomarker NT-proBNP in blood, provides guidance for the patients suspected to have heart failure whether they are in the emergency room or at the clinic. It also gives a general advise on how to prevent heart failure in diabetic patients. This algorithm is not applicable for BNP. By using the application, the user takes full responsibility for the results generated by the algorithm and for the clinical decision regarding the patient being evaluated. The user understands that the result and recommendations of the application are not intended to replace clinical judgment. The user also agrees that the developer is not responsible for any claim, damage or problem arising from the use of the application. This application was developed with financial support of Roche Diagnostics. However Roche Diagnostics takes no responsibility for the functionality or performance of the application.

Observe, user-friendly app designed for healthcare professionals to assess heart failure with preserved ejection fraction, featuring the Heart Failure Association (HFA) of the European Society of Cardiology (ESC) scoring systems: HFA-PEFF and H2FPEF (U.S. Score) guidelines. A precise tool to calculate HFpEF risk score using functional, morphological, and biomarker data. It gives a probability and percentage estimation of HFpEF, aiding diagnosis. However, it's not a substitute for professional medical advice or diagnosis. Healthcare providers should rely on comprehensive medical evaluations and their expertise when interpreting results.